Link Pharma Chem flips to a ₹7.69 lakh profit for FY26

Link Pharma Chem closed FY26 with a net profit of ₹7.69 lakhs, a pivot from the ₹102.73 lakhs loss reported in FY25. For a company with a market cap of only ₹13 crore, the shift moves the needle on the balance sheet but does little to alter the company's standing as a nano-cap. The annual figure masks volatility within the year, specifically a ₹40.86 lakh loss in the final quarter. Beyond the bottom line, the filing contains nothing that changes the outlook for the business. The re-appointment of two directors is a routine governance procedure. Investors should view these numbers as a simple accounting reality rather than a sign of operational expansion. The next test is whether the company can sustain its momentum or if it will return to the losses seen in previous cycles.